Pharmaceutical Technology

NOVEMBER 4, 2022

of gross domestic product (GDP) in R&D by 2027. In support of this, Turner says that the budget for Innovate UK , the funding agency that provides grants to life science companies, was increased by 30% over the last few years. UK’s competitive potential.

Documentation 93

Documentation Pharmaceutical Companies Pharmaceutical Companies 93

pharmaphorum

JANUARY 27, 2023

On the report’s findings, Steve Bates OBE, CEO of the BIA, said: “UK-based life sciences companies are worldleading in developing life changing medical innovation. Bates continued: “We expected a fall in investment following two bumper years, but it should still be considered a warning.

Compounding 52

Compounding Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

MARCH 7, 2024

billion between 2022 to 2027. Lastly, there is growing prominence and interest in radioligand therapeutics within major pharmaceutical companies, who are increasingly investing in this field, evident through recent acquisitions of Point Biopharma and RayzeBio.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Immunization FDA 52

Viseven

JUNE 12, 2023

from 2022 to 2027. Specifically, she engaged with several important stakeholders and received valuable information about future sales and marketing strategies, decision-making vision, and innovation trends among Chinese pharmaceutical companies. This role is significant because the pharma market in APAC is increasing.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 52

The Checkup by Singlecare

JANUARY 18, 2024

The patent protection for Nexplanon typically prevents other pharmaceutical companies from creating a generic version until the patent expires. in 2027 and other countries in 2025, when a generic version may be approved. Currently, there isn’t a generic equivalent available on the market.

Insurance 52

Insurance Insurance Coverage Packaging Pharmaceutical Companies 52

ISPE

SEPTEMBER 29, 2023

Takeda is the first pharmaceutical company worldwide to have implemented this water preservation project, in collaboration with a Belgian start-up Ekopak, on a large scale. Their overall goal is to reduce freshwater withdrawal by 90% by 2027 (the equivalent of 600 million liters of freshwater).

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling Patient Care 52

Pharmaceutical Technology

JANUARY 10, 2023

There are multiple drugs in the pipeline, predominantly me-too and biosimilar therapies, with a significant number developed in the emerging markets of India and China by domestic pharmaceutical companies for their own rapidly growing markets.

Labelling 52

Labelling Compounding Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JANUARY 6, 2022

The EU4Health 2021-2027 budget earmarks €5.3bn to, among other actions, strengthen health data and digital transformation across the EU. Sarah Rickwood has 30 years’ experience as a consultant to the pharmaceutical industry, having worked in Accenture’s pharmaceutical strategy practice prior to joining IQVIA.

Vaccines 111

Vaccines Pharmaceutical Companies Pharmaceutical Companies 111

Omnicell

JANUARY 10, 2023

Starting next year, Medicare will negotiate directly with pharmaceutical companies to set the maximum fair price (MFP) for certain prescription drugs, with the application of the negotiated prices starting in 2026 for 10 negotiation-eligible drugs from Part D. ” Sen. John Barrasso (R-Wyo.) Impact on 340B?

Hospitals 52

Hospitals Omnicell Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

APRIL 24, 2023

As a result, some pharmaceutical companies are turning to third parties. GlobalData forecasts Biologics to significantly overtake sales of small molecules by $120 billion by 2027. Moreover, skilled manpower is required to run these facilities.

Vaccines 52

Vaccines Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

FEBRUARY 6, 2023

A Pliant spokesperson said, “This successful transaction, along with existing cash, cash equivalents, loan agreement and short-term investments, provides for operations to be funded to mid-2027, a year past the expected IPF Phase 2b clinical trial readout.” The company said a Phase IIb trial initiation should be expected in mid-2023.

FDA 59

FDA Pharmaceutical Companies Pharmaceutical Companies Communication 59